The U.S. Food and Drug Administration (FDA) has added new restrictions on how rosiglitazone-containing medicines (Avandia, Avandamet, Avandaryl): Healthcare providers must enroll in a special program in order to prescribe the medicines, and patients must enroll in the same program in order to obtain their medicines through the mail. After November 18, 2011, rosiglitazone-containing medicines will no longer be available through retail pharmacies. Read more.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder